codevelopment agreement

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

FIND, Unitaid Ink First Agreement to Enable COVID-19 Antigen Tests at $2.50 Apiece

Biodesix, HiberCell Partner to Develop Companion Diagnostic Test for Oncology Immunotherapy

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test

Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD

Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

BARDA Agreement to Provide up to $69M for T2 Biosystems

Abionic, Genentech Partner to Develop POC Asthma Test

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Chembio Diagnostics, Shire Human Genetic Therapies Collaborate to Develop POC Biomarker Test

Chembio Diagnostics, Perseus Science Ink Agreement to Advance Point-of-Care Concussion Test

Breath Diagnostics, Mayo Clinic Laboratories Partner to Develop Lung Cancer Breath Test

CDC, Group K Diagnostics Collaborate to Design, Evaluate Zika POC Test